← Back to Treatments
🏅 FDA Orphan Designation

Lupron Depot-Ped

Leuprolide acetate

Manufacturer: AbbVie Endocrine Inc.

Indicated for:
Rare central precocious pubertyOrphan

FDA-Approved Indications (1)

treatment of pediatric patients with central precocious puberty (CPP)

Indications & Usage

1 INDICATIONS AND USAGE LUPRON DEPOT-PED is indicated for the treatment of pediatric patients with central precocious puberty (CPP). LUPRON DEPOT-PED is a gonadotropin releasing hormone (GnRH) agonist indicated for the treatment of pediatric patients with central precocious puberty. ( 1 )

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.